Detalles de la búsqueda
1.
Discovery of Di- and Trihaloacetamides as Covalent SARS-CoV-2 Main Protease Inhibitors with High Target Specificity.
J Am Chem Soc
; 143(49): 20697-20709, 2021 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34860011
2.
Expedited Approach toward the Rational Design of Noncovalent SARS-CoV-2 Main Protease Inhibitors.
J Med Chem
; 65(4): 2848-2865, 2022 02 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-33891389
3.
Discovery of SARS-CoV-2 papain-like protease inhibitors through a combination of high-throughput screening and FlipGFP-based reporter assay.
bioRxiv
; 2021 Mar 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-33758866
4.
Discovery of SARS-CoV-2 Papain-like Protease Inhibitors through a Combination of High-Throughput Screening and a FlipGFP-Based Reporter Assay.
ACS Cent Sci
; 7(7): 1245-1260, 2021 Jul 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-34341772
5.
Ebselen, disulfiram, carmofur, PX-12, tideglusib, and shikonin are non-specific promiscuous SARS-CoV-2 main protease inhibitors.
bioRxiv
; 2020 Sep 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-32995786
6.
Ebselen, Disulfiram, Carmofur, PX-12, Tideglusib, and Shikonin Are Nonspecific Promiscuous SARS-CoV-2 Main Protease Inhibitors.
ACS Pharmacol Transl Sci
; 3(6): 1265-1277, 2020 Dec 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33330841
7.
Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease.
Cell Res
; 30(8): 678-692, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32541865
8.
Structure and inhibition of the SARS-CoV-2 main protease reveals strategy for developing dual inhibitors against Mpro and cathepsin L.
bioRxiv
; 2020 Jul 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-32766590
9.
Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against Mpro and cathepsin L.
Sci Adv
; 6(50)2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33158912
Resultados
1 -
9
de 9
1
Próxima >
>>